Stock Information
IDEXX Laboratories Inc (IDXX)
Ticker Symbol: IDXX
Exchange: NASDAQ
Sector: Health Care
Market Cap: $42,232.38 mil
Piotroski score: 8
PE Ratio: 35.92
EPS (TTM): 14.23
Revenue (TTM): $57.41 M
Dividend Yield: N/A
ROE: 71.96%
Latest News
-
Companion Animal Diagnostic Market Forecasts Growth from $3.56B (2026) to $5.40B by 2031, Profiling IDEXX Laboratories & Zoetis
Thu, Sep 24, 2026 10:19 AM
-
Should You Continue to Hold IDXX Stock in Your Portfolio?
Wed, Sep 23, 2026 12:53 PM
-
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
Sun, Sep 20, 2026 3:02 PM
-
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference
Sun, Sep 20, 2026 2:02 PM
-
IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics
Sat, Sep 19, 2026 8:17 PM
-
IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide
Fri, Sep 18, 2026 3:15 AM
-
IDEXX Laboratories (IDXX) Could Be 29% Below Fair Value As Diagnostics Growth Stays In Focus
Thu, Sep 17, 2026 10:16 PM
-
IDEXX Stock Gains Following the Acquisition of CoVet
Thu, Sep 17, 2026 1:08 PM
-
Is IDEXX’s Expanded Zoonosis Testing Menu Altering The Investment Case For IDEXX Laboratories (IDXX)?
Thu, Sep 17, 2026 11:11 AM
-
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
Thu, Sep 17, 2026 7:00 AM
Key Financials
Financial data not available
